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Systems Biomedicine (see for instance Antony et al., 2012) is a
field in perpetual development. By definition a translational dis-
cipline almost holistically centered on the patient, it emphasizes
in light of its multifaceted characterization the need of assess-
ing its constitutive components as a system, whose dynamics
occur across multiple and hierarchical scales (organs, tissues,
cells, molecules).
A principal role in systems approaches is played by quantita-
tive inferencemethods resolving problems of high complexity and
uncertainty levels. Not surprisingly, it is expected that complex
systems may generate information from heterogeneity of sources
and diversity of components. Researchers can use this informa-
tion to look for data patterns with a signal-to-noise ratio which
help explaining variation and interdependent phenomena (gene
expression and methylation, pervasive transcription, alternative
splicing etc.).
Next-Gen technologies and Electronic Medical/Health
Records are providing researchers with data resources correctly
classified as “Big Data” (Pathak et al., 2013). The management of
such resources implies that a cross-disciplinary approach must be
put in place, involving team work targeting multiplexed research
topics (clinical, experimental, omics, high-content imaging, etc.)
whose separate analysis would not be as informative as their
synergistic fusion. In parallel, the growing impact of integration
of medical records, epidemiological studies and quantitative
measures referred to patients is increasingly expanding the
frontier of personalized or individualized medicine by leveraging
on a multi-evidenced mosaic of information designed to improve
patient-specific profiling.
While in principle it clearly appears from the most recent
literature what systems biomedicine is aiming to achieve, and
the attention is now on what instruments are needed, a main
question to pose is: How fast and effectively are we mov-
ing into this translation? Given the current speed at which
the translation is taking place, there are cultural, technical
and methodological bottlenecks that need be solved. The pro-
posed Special Topic on “Comprehensive Systems Biomedicine”
overviews the path of progression of the field along three main
axes:
(1) Data: once the accessibility is guaranteed and the dimension-
ality is managed, these will require novel generation analytics
to discriminate between signal and noise and thus reveal
with accuracy the inherent verifiability, relevance, complete-
ness, prediction power making of the data optimal candidate
for integrative inference approaches. The non-coding RNA
role is being increasingly revealed by high-throughput stud-
ies (The ENCODE Project Consortium, 2004; Harrow et al.,
2012) in both healthy and diseased conditions, but refers also
to the possibility of re-using data from previous technolo-
gies, i.e., microarray, as shown by the contributed work on
neuropathic pain. Then, this role is destined to have a strong
impact in pluripotency and neural differentiation of hESCs
and ihPSCs (following Li et al., 2011). Also, data integra-
tion is currently a major topic, in particular with reference
to profiling and pathway annotation of large-scale cancer cell
lines.
(2) Methods: when modularly designed and semi-parametric,
methods guarantee wide-spectrum applicability. Hybrid
pipelines can take advantage of different quantitative
approaches (statistics, machine learning, optimization, con-
trol, graph theory) combining multiple platform outcomes,
with analyzers and optimizers outflowing into metadata and
visual frameworks. Molecular interaction network approaches
in pharmacology are reviewed in a contributed study, while
in another study magnetic resonance techniques are discussed
with regard to morphological and physiological character-
izations of cancer tissue in vivo. Finally, a study is presented
for pathway, network, and multiplex methods in the context of
brain data.
(3) Systems: an organized functionally interactive aggregate
of entities operating under coordinated and harmonic
rules in normal conditions, should be comparatively eval-
uated against altered (disordered, dysregulated, etc.) con-
ditions to assess phenotypic variations determining the
systems characteristics preventively or prospectively, at
disease onset and pre/post intervention. In one exam-
ple, the integration of cytokines, lipoproteins, tissue pro-
teins, and histology indexes cast within a statistical model
to study plaque growth opens for new possible inter-
pretations of the atherogenesis inflammatory disorder. In
another study, the modeling of metabolism is consid-
ered and an algorithm proposed to detect functional
groups from existing databases and to identify metabolites,
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and from the perspective of pandemic studies. Then, a
study introduces an information system for precision oncol-
ogy designed for the integration of data and real-time
processing of samples with the computational analysis of
genomic alterations andmutations observed in themolecular
profiles.
The three axes—Data, Methods, Systems—can be naturally inte-
grated through key properties (such as compatibility, transferabil-
ity, generalizability), characteristic features and state-of-the-art
tendencies.
The communication across the axes is established on
the basis of the specific application domains. The final
impacts (clinical, societal, etc.) depend on both axis priori-
tization and solutions that are selected to optimize the key
properties.
While much work is on the way for empowering systems
approaches to enable a change in biomedical research, we hope
that the newly presented studies in this Special Topic can offer
opportunities to appreciate the current endeavors and prospective
potential in this field.
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